Next Quarterly Earnings
Wednesday, November 4, 2026
CW 45
Pre-Market
In 69 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals develops innovative medicines for rare, life-threatening diseases. The company focuses on orphan drugs built upon proprietary nucleotide-based technology. BioCryst's pipeline aims to address unmet medical needs, particularly in the areas of rare hemophilias and metabolic disorders.
Frequently asked questions
When will BioCryst Pharmaceuticals report its next quarterly earnings?
BioCryst Pharmaceuticals is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did BioCryst Pharmaceuticals last report quarterly earnings?
BioCryst Pharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 0.30 USD.
How does BioCryst Pharmaceuticals stock react to earnings?
Across its last 3 earnings reports, BioCryst Pharmaceuticals stock moved by ±4.4% on average the following day. The largest reaction was -6.3% on 11/03/2025; 1 of 3 reactions were positive.
How often has BioCryst Pharmaceuticals beaten expectations?
BioCryst Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the BioCryst Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±4.4%
Avg. next-day move
-6.3%
Largest move (11/03/2025)
33.3%
Share of positive reactions
±6.8%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
-903.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
BioCryst Pharmaceuticals
Country
🇺🇸
More Financial Information